We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ATOS market cap is 121.42M. The company's latest EPS is USD -0.1974 and P/E is -4.76.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.98M | -7.11M | -6.38M | -7.15M | -7.41M |
| Net Income | -5.88M | -6.05M | -7.23M | -6.35M | -6.72M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -15.55M | -20.61M | -27.69M | -31.38M | -27.62M |
| Net Income | -22.33M | -20.61M | -26.96M | -30.09M | -25.5M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 91.09M | 85.86M | 79.48M | 76.44M | 70.75M |
| Total Liabilities | 5.33M | 5.7M | 5.8M | 4.97M | 5.43M |
| Total Equity | 85.76M | 80.16M | 73.68M | 71.48M | 65.32M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 42.84M | 141.26M | 123.53M | 96.25M | 76.44M |
| Total Liabilities | 15.67M | 3.13M | 5.57M | 5.24M | 4.97M |
| Total Equity | 27.17M | 138.14M | 117.96M | 91.02M | 71.48M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.7M | -9.23M | -13.98M | -21.03M | -5.96M |
| Investing | -6k | -9k | -19k | -19k | -9k |
| Financing | 204k | 304k | 304k | 3.67M | N/A |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.57M | -16.47M | -20.76M | -20.94M | -21.03M |
| Investing | -9k | -9k | -4.73M | -14k | -19k |
| Financing | 38.55M | 113.3M | N/A | -1.48M | 3.67M |
| Market Cap | 121.42M |
| Price to Earnings Ratio | -4.76 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.71 |
| Price to Book Ratio | 1.7 |
| Dividend Yield | - |
| Shares Outstanding | 129.17M |
| Average Volume (1 week) | 735.45k |
| Average Volume (1 Month) | 1.61M |
| 52 Week Change | -21.67% |
| 52 Week High | 1.66 |
| 52 Week Low | 0.5526 |
| Spread (Intraday) | 0.01 (1.2%) |
| Company Name | Atossa Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.atossatherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
